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The article analyses to what extent the use of brands on packaging in the field of tobacco, alcohol 
and food can be prohibited or restricted by governments to protect consumers’ health. After 
introducing the most important packaging-related measures adopted or proposed in the industries 
in question and highlighting the differences between the concepts of “registration” and “use” of 
brands, the paper will make the point that the TRIPS Agreement and the Paris Convention do not 
offer trademark owners a positive right to use brands, but just a negative right (i.e. the right to 
prevent third parties from exploiting the sign), which makes the measures analysed in the paper 
lawful and compliant with those international treaties. In light of the evidence gathered thus far, the 
measures in question seem also to be capable of meeting the desired target, namely consumers’ 
health.  
 
 
 
Introduction 
 
This study aims to analyse the extent the use of brands, especially on packaging, can be prohibited 
or restricted by public authorities to protect consumers’ health. The analysis appears to be timely as 
of late a wave of regulatory measures have been adopted or proposed in several jurisdictions which 
prevent manufacturers of harmful products from fully using their trademarks in order to embellish 
and promote their goods. The products which have been particularly targeted by such measures are 
tobacco, alcohol and (what is considered) unhealthy food.1 
 
After introducing the most important packaging-related measures adopted or proposed in the 
industries in question, I will delve into the debate about whether the TRIPS Agreement and the 
Paris Convention offer trademark owners just a negative right (i.e. the right to prevent third parties 
from exploiting the sign) or also the positive right to use it. By highlighting the difference between 
the concepts of “registration” and “use” of brands and other relevant issues, I will conclude that just 
a negative right is offered, which makes the measures analysed in the paper lawful and compliant 
with those international treaties. I will also verify whether such measures are effective and 
compliant with specific TRIPS’ provisions on trademarks and the protection of public interests. 
 
                                                 
(*) The initial research that led to the final version of this article has been carried out during my visiting fellowship 
period at Melbourne Law School (Autralia) during Fall 2013. I wish to thank for useful discussions and suggestions 
Alberto Alemanno, Jason Bosland, Andrew Christie, Mark Davison, Brian Fitzgerald, Heather Ann Forrest, Jonathan 
Griffiths, Dan Hunter, Andrew Mitchell, Chantal Morton, Sam Ricketson, Marco Ricolfi, Amanda Scardamaglia and 
Tania Voon. 
1
 The adoption of most of these measures has been triggered by a set of international regulatory instruments, e.g, the 
legally binding WHO Framework Convention on Tobacco Control (FCTC)1 as well as certain soft law instruments such 
as the WHO Strategies on Alcohol and Diets, the 2011 United Nations (‘UN’) Political Declaration on NCDs and the 
WHO Global Action Plan for the Prevention and Control of NCDs 2013-2020. See also the WHO Global Strategy to 
Reduce the Harmful Use of Alcohol (2010), WHA63.13; WHO Global Strategy on Diet, Physical Activity and Health 
(2004), WHA57.17; Political Declaration of the High-level Meeting of the General Assembly on the Prevention and 
Control of Non-communicable Diseases, GA Res 2, UN GAOR, 66th sess, 3rd plen mtg, UN Doc A/Res/66/2 (2012); 
WHO Global Action Plan for the Prevention and Control of NCDs, Resolution WHA66.10 endorsed by the 66th WHO 
World Health Assembly. 
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The scope of the analysis will not be limited to just one jurisdiction – I will instead take into 
account several regulatory measures adopted or proposed in Europe, United States, Australia and 
other countries. A significant number of national and international disputes will also be considered. 
The paper will not cover restrictions on use of brands in the pharmaceutical industry, which also 
experiences limitations on public health grounds: these measures are out of scope of the present 
analysis. 
 
Regulatory measures which restrict the use of trademarks in the fields of tobacco, alcohol and 
food 
 
Generally speaking, companies tend to present their goods in such a way as to induce consumers to 
make purchase decisions. Brands affixed on packaging, including fancy words, logos and colours, 
are the privileged means to communicate this message to prospective purchasers. It therefore does 
not come as a surprise that more and more regulators and policy makers around the world have 
started adopting measures that prohibit or restrict the use of trademarks on packaging in connection 
with products that are considered harmful. Their aim is to make such goods less appealing and thus 
discourage consumption, mainly on the assumption that less exposure of existing and potential 
customers to brands and other packaging features reduces the chances of purchase.2 
 
Tobacco 
 
The case of tobacco is particularly relevant. Measures have recently been adopted or proposed that 
aim to prevent tobacco companies from fully displaying on packaging the fancy elements of their 
trademarks. The most striking example within this category of measures is plain packaging of 
tobacco products. Bans on misleading packaging and compulsory health warnings have also been 
adopted which aim at avoiding consumers’ deception about the health consequences of tobacco 
consumption. 
 
Also known as “generic” or “standardised packaging”, plain packaging requires that all forms of 
tobacco branding be labelled exclusively with simple, unadorned text. This entails that trademarks, 
graphics and logos be removed from cigarette packs, except for the brand name and variant, which 
are displayed in a standard font identical for all brands in the market. In essence, plain packaging 
aims at standardising the appearance of all cigarette boxes in order to make them unappealing,3 
especially for adolescents, thus reducing the prevalence and up-take of smoking. To the eyes of 
tobacco majors, this is a strong limitation of their commercial freedom, especially in those countries 
where almost all forms of tobacco advertising are prohibited and thus packaging has become their 
ultimate marketing tool. Indeed, cigarette packs, once opened, remain in the hands of final 
consumers and constitute a powerful means of “mobile” advertising.4 
 
                                                 
2
 See Rebecca Tushnet, “Gone in Sixty Milliseconds: Trademark Law and Cognitive Science” (2008) Texas Law 
Review, Vol. 86 Issue 3, 508 (noting in particular that “cognitive science is especially attractive to trademark law 
because trademark protection is premised on a psycological assumption: exposure to a mark will trigger ideas and 
emotions in the mind of a consumer”). 
3
 See Becky Freeman, Simon Chapman and Matthew Rimmer, “The Case for the Plain Packaging of Tobacco Products” 
(2007) 103(4) Addiction 580; Alberto Alemanno and Enrico Bonadio, “The Case of Plain Packaging for Cigarettes” 
(2010) 3 European Journal of Risk Regulation, p. 268. 
4
 Plain packaging is endorsed by the FCTC, and more precisely by the guidelines to Arts 11 and 13 to this treaty, which 
expressly recommend that states consider adopting such measures. See WHO Framework Convention on Tobacco 
Control: Guidelines for Implementation (2011) 59, 95–96 (“Guidelines to the WHO FCTC”).  
Plain packaging has been implemented in Australia.5 It has also been recently announced or taken 
into serious consideration in Ireland and United Kingdom6 as well as South Africa, New Zealand 
and India.7 Also, in March 2014 the EU adopted a revised EU Tobacco Products Directive.8 While 
the new directive does not mandate plain packaging, it leaves EU Member States free to introduce 
such measure. The Australian legislation on plain packaging has been challenged by leading 
tobacco majors such as British American Tobacco Australasia Limited and Philip Morris Asia 
Limited before both the High Court of Australia9 and an ICSID arbitral panel constituted pursuant 
to a bilateral investment treaty (“BIT”) between Australia and Hong Kong.10 A dispute is also 
currently pending at the World Trade Organization (“WTO”), which regards the compatibility of 
the Australian measure with several provisions of the TRIPS Agreement - and a decision is 
expected soon.11 
 
Other measures related to the presentation of tobacco products are in force in Uruguay. Uruguayan 
legislation prohibits misleading or deceptive tobacco packaging - and thus aims at correctly 
informing consumers about health consequences.12 The aim is to protect people’s health. Initially 
this provision was invoked to outlaw descriptors including “mild”, “light” and “ultra-light” (which 
are often incorporated in registered trademarks owned by tobacco companies). After Philip Morris 
began using different brands differentiated by colours and terms referring to such colours instead of 
the above descriptors (such as “Gold”, “Blue”, “Silver”), the Uruguayan Ministry of Public Health 
interpreted the ban on deceptive and misleading packaging as also outlawing the use of different 
colours on the packaging. Philip Morris challenged this provision under the BIT between Uruguay 
and Switzerland,13 claiming that the effect of the way the Uruguayan provision on deceptive and 
misleading packaging has been interpreted and applied entailed that just one product from a brand 
family can be marketed in that country,14 with the result that tobacco manufacturers would be 
unable to fully use their trademark portfolio.15 Some commentators have labelled this measure as 
                                                 
5
 Tobacco Plain Packaging Act 2011 (Cth) ch 2. 
6
 See the Irish Outline Heads of the Public Health (Standardised Packaging of Tobacco) Bill 2013 as well as the UK 
plain packaging Draft Regulations at  
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/323922/Cons_doc.pdf (last accessed on 
18 September 2014). 
7
 Peter Leung, “Why Asia is set for more tobacco plain packaging rules” (2013) Managing Intellectual Property, 227, p. 
14. 
8
 Directive 2014/40/EU of the European Union and of the Council of 3 April 2014 on the approximation of the laws, 
regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of 
tobacco and related products and repealing Directive 2001/37/EC. On the legislative process which led to the adoption 
of this directive see Matthew J. Elsmore and Viktoria Obolevich, “Thank you for not smoking: the Commission’s 
proposal for a new Tobacco Products Directive – legally sound, but does it hit the spot?” (2013) European Law Review 
38(4), pp. 552-572. 
9
 In August 2012 the Australian High Court confirmed that the measure did not amount to an expropriation of the 
tobacco companies’ (intellectual) property and is thus compliant with Australian Constitution (JT International SA v 
Commonwealth [2012] HCA 43). For a comment of the decision see Jonathan Liberman, “Plainly Constitutional: the 
Upholding of Plain Tobacco Packaging by the High Court of Australia” (2013) 39(2) American Journal of Law and 
Medicine, 361-381; Sam Ricketson, “Plain packaging legislation for tobacco products and trade marks in the High 
Court of Australia” (2013) Queen Mary Journal of Intellectual Property, Vol. 3 No 3, pp. 224-240. 
10
 Agreement between the Government of Hong Kong and the Government of Australia for the Promotion and 
Protection of Investments, signed on 15 September 1993, 1748 UNTS 385 (entered into force 15 October 1993). 
11
 Complaints against Australian legislation have been brought by Ukraine, Honduras, Indonesia, Dominican Republic 
and Cuba. 
12
 Law No 18,256 (2008) (Uruguay) 29 February 2008. 
13
 Agreement between the Swiss Confederation and the Oriental Republic of Uruguay Concerning the Reciprocal 
Promotion and Protection of Investments, signed 7 October 1988, 1976 UNTS 413 (entered into force 7 October 1988). 
14
 Benn McGrady, “Implications of Ongoing Trade and Investment Disputes Concerning Tobacco: Philip Morris v 
Uruguay” in Andrew Mitchell, Tania Voon and Jonathan Liberman (eds), Public Health and Plain Packaging of 
Cigarettes: Legal Issues (Edward Elgar, 2012), pp. 173 and 178.  
15
 McGrady, cited above fn. 14, pp. 173 and 178. 
the “single presentation requirement”, as it bans the presentation of a single brand in multiple forms 
if such forms are capable of misleading consumers about the risk of smoking.16 In the eyes of the 
challenger, Philip Morris, this measure is arbitrary and not reasonably justified by a public health 
objective and thus amounts to an unlawful expropriation of (intellectual) property. The dispute is 
still pending.17 
 
Another category of packaging-related measures relates to health warnings, i.e. messages to be 
included on the packaging concerning the effects of consumption. They have been implemented in 
several jurisdictions with a view to enhancing consumers’ awareness of the harmful effects of 
smoking and thus discouraging consumption – and their effect is to limit the space available for 
brands on the packaging. For example, the recent EU Tobacco Directive requires cigarettes makers 
to show on packs health warnings covering a minimum of 65% of the front and back surfaces 
started from top edge.18 In Uruguay all health warnings are required to cover 80% of the front and 
80% of the back of all cigarette packages.19 
 
Food 
 
Health warnings are also spreading to certain foodstuff, thus enlarging the range of trademark 
owners hit by this marketing restriction. For instance, Chile recently amended its Food Health 
Regulation that mandates to place “STOP” signs on high fat, sugar and salt (HFSS) foods, such 
signs occupying no less than 20% of the main surface of the package.20 And in the US, the 
California Senate Appropriations Committee is deliberating a bill that would require drinks 
manufacturers to place the following health warning label on all sweetened non-alcoholic drinks: 
“Drinking beverages with added sugar(s) contributes to obesity, diabetes, and tooth decay”.21 Also, 
Peru introduced similar legislation in 2013, namely the Act to Promote Healthy Eating amongst 
Children and Adolescents, that mandates warnings on packaging such as “high in calories”, or 
“high salt” on food products.22 
 
Protection of children is also the target of a recent South African and EU measure aimed at 
promoting breastfeeding, i.e. the ban on the use of logos on infant formula packaging containing 
pictures of babies or (in the case of South Africa, also) other humanised figures.23 
                                                 
16
 See also World Health Organization, “Confronting the Tobacco Epidemic in a New Era of Trade and Investment 
Liberalization” (2012), pp. 59–60. 
17
 See also Benn McGrady, “Philip Morris v. Uruguay: The Punta del Este Declaration on the Implementation of the 
WHO Framework Convention on Tobacco Control” (2011) 2 European Journal of Risk Regulation, p. 254. 
18
 See above fn. 8. 
19
 See again Law No 18,256 (2008) (Uruguay) 29 February 2008. 
20
 See the WTO press release following the latest meeting on 5-7 March 2013 of the Technical Barriers to Trade (TBT) 
Committee at http://www.wto.org/english/news_e/news13_e/tbt_13mar13_e.htm, last accessed on 18 September 2014. 
21
 See BMJ’s article of 27 May 2014, available at http://www.bmj.com/content/348/bmj.g3428, last accessed on 18 
September 2014. 
22
 Peru — Act 30.021 to Promote Healthy Eating Among Children and Adolescente, 13 May 2013. 
23
 See Regulation 7 of R991, published regulations in terms of s. 15(1) of the Foodstuffs, Cosmetics and Disinfectants 
Act, 54 of 1972. South-African consumers therefore no longer see pictures on infant and follow-up formula for special 
dietary or medical purposes; liquid milks, powdered milks, modified powdered milks, or powdered drinks marketed or 
otherwise represented as suitable for infants or young children; feeding bottles, teats and feeding cups with spouts, 
straws or teats or complementary foods. See also Article 10(2) of EU Regulation No 609/2013. 
This measure echoes an old Guatemalan case that also regarded marketing of infant formula milk. In 1983 Guatemala 
implemented the WHO’s International Code of Marketing of Breast-milk Substitutes, which prohibited the use of 
images of babies on foods destined for children under the age of two. The goal of this legislative move was to protect 
the lives of infants by promoting breast-feeding over breast milk substitutes and, particularly, to thwart aggressive 
marketing by baby food companies aimed at convincing mothers that their products were superior to breast milk. The 
law specifically banned images that idealised the products in question. Facing its implementation, the US children’s 
food company Gerber claimed that the law infringed its trademark, which included the image of a healthy baby. Gerber 
Alcohol 
 
Alcoholic products have also been the target of recent regulatory measures. For example, Turkish 
legislation now requires placement of three graphic images depicting that alcohol should not be sold 
to minors, consumers should not drink and drive and alcohol should not be consumed by pregnant 
women. The statement on the packaging that “alcohol is not your friend” is also required.24 
Thailand also has a liquor labelling regime in place that mandates graphic warnings and accordingly 
shrinks the space available for brands on the packaging.25 
  
A particular measure aimed at reducing the attractiveness of certain alcoholic products had been 
adopted in Iceland back in 1998. This measure was challenged in the Hob-vìn ehf case before the 
European Free Trade Association Court (“EFTA Court”). It was found not to be compliant with the 
Agreement on the European Economic Area.26 The most interesting part of this dispute regards the 
refusal by the State Alcohol and Tobacco Company of Iceland (“ATVR”) to authorise the 
marketing and sales of three cider cans, which had been legally manufactured and sold in Denmark. 
The reason for such refusal was that their packaging bore text and visual imagery in violation of a 
provision adopted by ATVR. The provision states that the text and images on alcoholic packaging 
and labelling should not suggest that the product enhances physical, mental, social or sexual 
functions; or offend people’s general sense of propriety, for example by referring to violence, 
religion, pornography, illegal drugs, political views, discrimination or criminal conduct. ATVR 
stressed that the packaging of the products in question (which were marketed in stylish cans, 
featuring artful drawings including colourful illustrations of women’s legs with some apparently 
naked skin) were “evidently intended to make the products sensually appealing and challenging”.27  
                                                                                                                                                                  
then began threatening Guatemala that the company would lobby the US State Department to encourage it to impose 
trade sanctions under the General Agreement on Tariffs and Trade 1947 (GATT 1947) and other trade measures (in 
particular, the withdrawal of Most Favoured Nation trading status). This move prompted the Guatemalan Supreme 
Court to exclude products imported into Guatemala, including those marketed by Gerber, from the application of the 
legislation. On this case see Russell Mokhiber, “Gerber Uses Threats of GATT Sanctions to Gain Exemption from 
Guatemalan Infant Health Law” (1996) 10(14) Corporate Crime Reporter, p. 6; Robert Mayer, “Protectionism, 
Intellectual Property and Consumer Protection: Was the Uruguay Round Good for Consumers?” (1998) Journal of 
Consumer Policy 195, 209. 
24
 For more information see the blog of the O’Neill Institute for National and Global Health Law at 
http://www.oneillinstitutetradeblog.org/wp-content/uploads/2013/11/13_3072_00_e.pdf, last accessed on 18 September 
2014. 
25
 In particular, Thai legislation requires labels to carry any of the following messages: (i) drinking alcohol causes 
hypertension liver cirrhosis; (ii) alcohol intoxication leads to accidents; (iii) drinking alcohol leads to unconsciousness 
and even death; (iv) drinking alcohol leads to inferior sexual performance; (v) drinking alcohol leads to adverse health 
effect and family problems; (vi) drinking alcohol is a bad influence on children and young people. It will also require 
the graphic health warning to be no less than 30% to 50% of the size of the alcohol container. The warning labels shall 
rotate every 1,000 packages. See the webpages of the Thai Alcohol and Tabacco Tax and Trade Buraeu at 
http://www.ttb.gov/itd/thailand.shtml, last accessed on 18 September 2014. 
26
 HOB-vín ehf v The State Alcohol and Tobacco Company of Iceland (ÁTVR) (EFTA Court, E-2/12, 11 December 
2012). For a timely comment on this case see Alberto Alemanno, “The HOB-vín Judgment: A Failed Attempt to 
Standardise the Visual Imagery, Packaging and Appeal of Alcohol Products” (2013) 1 European Journal of Risk 
Regulation, p. 101. The European Economic Area Agreement was signed on 2 May 1993, 1801 UNTS 3 (entered into 
force 1 January 1994) (“EEA Agreement”) and extends portions of European Union law to European Economic Area 
countries including Iceland. 
27
 The importer of the cans challenged this decision. The case was then referred to the EFTA Court, which was asked to 
give an advisory opinion about the compatibility of the Icelandic provision with the EEA Agreement (in general, this 
court has the task of interpreting the EEA Agreement with regard to the EFTA countries that are party to it, namely 
Iceland, Liechtenstein and Norway. EFTA is a free trade organisation grouping Iceland, Liechtenstein, Norway and 
Switzerland). The EFTA Court noted that the refusal by ATVR had been based exclusively on a specific part of the rule 
in question, namely the part of the provision that prohibits the use of texts or visual imagery that offends people’s 
 Even though the Icelandic provision was eventually condemned for being contrary to the EEA 
Agreement, this case shows that policymakers have started targeting the packaging and brands of 
alcoholic products. 
 
Trademarks as negative rights 
 
All the above measures have been adopted with a view to both informing consumers about the 
health risks associated with the consumption of harmful products and discouraging consumption 
itself. Yet, they also prevent trademark owners from fully using their brands on packaging: e.g. 
plain packaging of tobacco products restricts the use of word signs and prohibits the use of 
figurative trademarks while health warnings, as we have seen, reduce the space available for brands 
on the packaging. Also, the single presentation requirement adopted by Uruguay limits the ability of 
tobacco manufacturers to use their family of brands. The same holds true of the South African and 
EU measures which ban the use of baby-related logos on infant formula packaging. 
 
The relevant issue is thus whether the measures in question infringe trademarks owned by tobacco, 
alcohol and food manufacturers. I here argue that they do not as such measures do not affect any 
right offered by trademark registrations. Indeed, what trademark registrations do offer is not the 
positive right to use a sign, but just a ius excludendi alios, namely the negative right to prevent 
others from exploiting the brand,28 which is not jeopardised by the measures in question. A sign can 
indeed be used by economic operators regardless of, and prior to, the registration by the trademark 
office, i.e. as soon as they start a business by offering the relevant products or services in the 
market.29 In other words, as will also be shown later,30 traders and companies have just a privilege 
(not a right) to use a brand, and registration by a trademark office restricts the privilege to use the 
sign. 
 
The fact that trademark registrations provide just negative right is confirmed by Article 16 TRIPS: 
“The owner of a registered trademark shall have the exclusive right to prevent all third parties not 
                                                                                                                                                                  
general sense of propriety. Accordingly, it was found that the measure in question could not be justified under the EEA 
Agreement by a stringent public interest objective such as the protection of public health (the ATVR had claimed in the 
proceedings that the ban in question could be justified by invoking the protection of consumers’ health). 
28
 It is opportune to stress this point as it seems that courts are still wrapped in confusion. A recent decision of the Court 
of Justice of the European Union (CJEU) confirms such confusion. In Martin Y Paz Diffusion SA v David Depuydt the 
CJEU was asked whether a trademark owner could be permanently prevented from exercising its exclusive rights and 
from using its trademark for certain goods because a third party has used the mark for these goods with the consent of 
the owner over an extended period of time (Martin Y Paz Diffusion SA v David Depuydt and another, Case C-661/11, 
decision of 19 September 2013). It held that under these circumstances the right owner cannot be deprived of any 
possibility of asserting the exclusive right conferred upon it by those trademarks against that third party and of itself 
exercising that exclusive right in respect of goods which are identical to those of that third party. It thus seemed to 
suggest that trademark registrations confer positive rights to use the sign. Yet, in his preliminarily opinion Advocate 
General Cruz Villalón expressly held the opposite opinion, namely that trademark rights are negative (AG’s opinion of 
18 April 2013, paragraph 90). 
29
 See also Julius R. Lunsford, “The Right to Use and The Right to Register – The Trade-Mark Anomaly” (1953) 
Trademark Reporter 43, pp. 1-28, at p. 6. Not all scholars accept the “negative right” argument, as will be highlighted 
infra. See Daniel Gervais, “Analysis of the Compatibility of certain Tobacco Product Packaging Rules with the TRIPS 
Agreement and the Paris Convention”, Report of 30 November 2010 (available at www.smoke-free.ca/trade-and-
tobacco/Resources/Gervais.pdf, last accessed on 18 September 2014); Daniel Gervais – Susy Frankel, “Plain Packaging 
and the Interpretation of the TRIPS Agreement” (2013) Vanderbilt Journal of Transnational Law, Vol. 46(5), pp. 1149-
1214; Annette Kur, “The right to use one’s own trade mark: a self-evident issue or a new concept in German, European 
and international trade mark law?” (1996) European Intellectual Property review, pp. 198-203, pp. 198-199 
(highlighting however German case law that suggest that owners of registered trademarks do not have a valid right to 
use); Ulf Bernitz, “Logo licensing of Tobacco Products” (1990) European Intellectual Property Review, 12/4, pp. 137-
139, at p. 139. 
30
 See infra the paragraph “The privilege to use a sign”.  
having the owner’s consent from using in the course of trade identical or similar signs”.31 And the 
fact that the registration does not offer its owner a positive right to use the trademark allows 
governments to introduce measures that prohibit or restrict such use on public interest grounds. As 
also has been confirmed by the WTO Panel in EC – Trademarks and Geographical Indications, the 
TRIPS agreement “does not generally provide for the grant of positive rights to exploit or use 
certain subject matter, but rather provides for the grant of negative rights to prevent certain acts. 
This fundamental feature of intellectual property protection grants Members freedom to pursue 
legitimate public policy objectives since many measures to attain those public policy objectives lie 
outside the scope of intellectual property rights and do not require an exception under the TRIPS 
Agreement”.32 
 
The above reading had also been confirmed by Advocate General Geelhoed in his Opinion on the 
validity of the 2001 EU Tobacco Products Directive: “the essential substance of a trademark right 
does not consist in an entitlement as against the authorities to use a trademark unimpeded by 
provisions of public law. On the contrary, a trademark right is essentially a right enforceable against 
other individuals if they infringe the use made by the holder” (emphasis added).33 
 
Arguments and counterarguments 
 
In the following paragraphs I will present and criticise arguments pushed by some scholars in 
support of the opposite opinion, namely that trademark registrations would also confer a positive 
right to use the sign. In doing so I will often refer to specific provisions of the Paris Convention and 
the TRIPS Agreement. 
 
The alleged “spirit” of TRIPS and Paris 
 
Some commentators argue that while the TRIPS Agreement and the Paris Convention (whose main 
provisions are incorporated in the former)34 do not expressly refer to a positive right to use a 
trademark, nonetheless the spirit of these two treaties is to allow the use of signs.35 It has also been 
argued that rights to property are often defined in a negative (i.e. as rights to exclude others) and not 
in a positive way just in order to facilitate governments’ actions for limiting such rights: “if 
property owner’s rights are not defined as rights to exclude from the property, laws affecting the 
property might be harder to make without expressly calling them exceptions to owner’s rights”.36 
 
                                                 
31
 See also Article 5(3) Trademark Directive; Article 9(1) Trademark Regulation; Recital 14 Directive 98/44/EC of the 
European Parliament and of the Council of 6 July 1998 on the Legal Protection of Biotechnological Inventions [1998] 
OJ L 213/13. The view that trademark rights are just negative is shared by most commentators. See for example Justin 
Malbon, Charles Lawson, Mark Davison “The WTO Agreement on Trade-Related Aspects Of Intellectual Property 
Rights – A Commentary” (2014), Elgar, paragraph 16(03); Carlos Correa, “Trade Related Aspects of Intellectual 
Property Rights. A Commentary on the TRIPS Agreement” (2007), OUP, p. 186 (noting that Article 16(1) “alludes to 
the right to exclude the use under certain conditions. It is clearly provided for as a negative right, and not as the right to 
use the trademark”). 
32
 European Communities — Protection of Trademarks and Geographical Indications for Agricultural Products and 
Foodstuffs (Complaint by Australia), WT/DS290/R, paragraph 7.246. 
33
 See Opinion of A.G. Geelhoed in British American Tobacco [2002] E.C.R. I-11453; [2003] 1 C.M.L.R. 14, at 266. 
34
 Article 2.1 TRIPS. 
35
 See for example Gervais, cited above fn. 29, paragraph 59.  
36
 Daniel Gervais – Susy Frankel, cited above fn. 29, at p. 1192 (citing Henry E. Smith, “Exclusion versus Governance: 
Two Strategies for Delineating Property Rights”, 31 Journal of Legal Studies 453 (2002)). 
The argument in question, based on alleged purposive interpretation37 of international trademark 
law provisions, seems flawed. First, as far as TRIPS is concerned, it is difficult to imply a positive 
right to use a trademark in the body of an international treaty that is all about “rights”, i.e. the 
Trade-Related Aspects of Intellectual Property Rights (emphasis added).38 States indeed do not 
cheerish the idea that they have accepted to offer rights which are not explicitly referred to in the 
body of a treaty they have negotiated.39 Also, if a positive right to use signs is (impliedly) conferred 
by the TRIPS Agreement, it is far from clear what the scope of this right is.40 Would it, for example, 
include the right to use brands for advertising harmful products such as tobacco, with the result that 
many legislations around the world that ban tobacco advertising be made unlawful? No doubt such 
an interpretation would jeopardise legal certainty. 
 
If TRIPS negotiators really meant to include a positive right to use a sign, they would have 
expressly mentioned and defined it in a specific provision, if not even in the heading of an article.41 
The WTO Panel in EC – Trademarks and Geographical Indications confirmed this view: “if the 
drafters had intended to grant a positive right, they would have used positive language. […] The 
right to use a trademark is a right that Members may provide under national law”.42 States thus 
retain the option to introduce such a right if they wish, as Australia seemed to have done in 1995 
when passing its Trade Marks Act (Section 20(1)).43 Yet the fact that a country passes trademark 
statutes that envisage a positive right to use signs does not prevent it from prohibiting or restricting 
the use of the marks when adopting legislative measures in the public interest. In most legal systems 
such measures indeed constitute lex specialis (because they are adopted just in specific sectors), 
such lex being capable of superseding general laws like IP legislations (lex specialis derogat legi 
generali, namely a special law repeals a general law). Australian plain packaging legislation, which 
was introduced in 2011 and limits the ability of tobacco manufacturers to use signs, should 
therefore be considered lex specialis and thus a legitimate derogation of the 1995 Australian Trade 
Marks Act (lex generalis)44 (still assuming that the former confers a positive right). Similarly, if a 
country introduces advertising restrictions in a specific field (e.g. alcohol), which have the effect of 
preventing the promotional use of alcohol-related brands in certain advertising-related scenarios, 
such measures would constitute a lawful derogation of trademark statutes which provide a positive 
right to use signs. 
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The argument that there would be no point in just exercising the right to exclude others from 
exploiting the registered sign if the owner cannot use it itself45 is also flawed. The negative right 
would still be useful as it would allow owners, especially well known trademark owners, to 
maintain the value of the sign for the purpose of licence in other fields (where lawful) and in 
particular, to prohibit infringing activities which could turn out to dilute the distinctiveness and 
image of the trademark in case the prohibition or restriction are subsequently repealed.46 
 
Interpretation of domestic trademark laws 
 
The TRIPS Agreement therefore does not mandate states to provide a positive right to use the 
registered trademark. It however leaves countries free to offer trademark owners such a right, if 
they so wish. 
 
Yet even national legislations which seem to confer a positive right to use the sign have been 
interpreted in a “negative” way. The Australian Trade Marks Act of 1995 is a case in point. Section 
20(1) of the Act provides that trademark owners have “the exclusive rights: (a) to use the trade 
mark; and (b) authorise other persons to use the trade mark […]”. Yet, in the domestic dispute 
concerning the constitutionality of the plain packaging legislation the Australian High Court, while 
stressing that trademark and in general IP rights are property rights47 that can be assigned,48 found 
that what trademark registrations offer are just negative rights. In particular, Justice Crennan held 
that “the exclusive right to use the mark is a negative right to exclude others from using it”.49 And 
Justice Kiefel stressed that “the right subsisting in the owner of a trade mark is a negative and not a 
positive right. It is to be understood as a right to exclude others from using the mark […]”.50 
Finally, Justice Gummow noted that “trade mark registration systems ordinarily do not confer a 
liberty to use the trade mark, free from what may be restraints found in other statutes or in the 
general law. […] All these items of ‘property’ are […] ‘artificial products of society’, not ‘physical 
objects’ the boundaries of each class of which are fixed by external nature; more precisely […] 
these are not affirmative rights like the property in goods and […] not rights ‘in gross, or in the 
abstract’ […]”.51 
 
Registration versus use 
 
The argument that trademark registrations would confer rights to use is often coupled with the point 
that if registrations are granted is because trademarks must be used in commerce,52 not because 
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their owners want to get just a certificate from the state.53 Registration without use would therefore 
be a “hollow formal right which is economically meaningless”.54 This interpretation would be 
reinforced – the argument goes – by the fact the provisions of the TRIPS Agreement and the Paris 
Convention which deal with registration issues also refer to use. For example, paragraph 3 of 
Article 15 states that “Members may make registrability depend on use […]” whereas paragraph 4 
provides that “the nature of the goods or services to which a trademark is to be applied shall in no 
case form an obstacle to registration of the trademark”.55 A contextual reading of these provisions 
would therefore suggest that the use of a trademark is inextricably linked to its registration and thus 
what trademark registrations confer on their owners are also positive rights to use the sign. 
 
The above arguments seem to go too far and in particular to confuse two concepts - registration and 
use of trademarks – that are different and autonomous instead.56 
 
First, the use of trademarks is covered by another provision, namely Article 20 TRIPS Agreement, 
which will be analysed infra. Also, the reference to Article 15(3) TRIPS does not lend weight to the 
“positive right” argument. By providing that states may make registratbility of trademarks depend 
on use, this article is also saying that countries do not have any obligation to make registration 
dependent on use, which confirms again that registration and use are different concepts.57 
 
Secondly, trademark registrations may have relevant economic value even when the signs in 
question are not yet used. Trademark registrations, for instance, may be assigned even where the 
relevant signs have not yet been used. Cases where trademark registrations are purchased by 
companies that later decide not to use the signs in question are not uncommon. This proves that 
registration may be economically valuable, at least for a certain period of time, regardless of any 
use of the underlying sign. Also cases where trademark owners keep registration alive despite not 
being able to use the sign are not rare. For example, despite being legally bound not to use 
descriptors such as “mild” and “light”, some tobacco companies have nonetheless renewed 
trademarks containing such descriptors.58 
 
Moreover, the real purpose of Article 15(4) TRIPS is to ensure that registration can occur even 
though the use of a trademark is not possible in connection with a particular product, for instance 
because the goods on which it should be affixed cannot be sold on security or safety grounds (e.g. a 
pharmaceutical product which can be marketed only after obtaining the relevant marketing 
authorisation).59 It is therefore implicit in such provision that, despite the registration, the use of 
trademarks may be restricted or even prohibited by governments under certain circumstances.60 
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 This interpretation has also been endorsed by a former Director-General of the World Intellectual 
Property Organization (WIPO), which administers the Paris Convention: “[…] Article 7 [Paris 
Convention, which is reproduced in Article 15(4) TRIPS and is also incorporated into the latter]61 
does not address the question of permission to use a registered mark. Therefore, countries party to 
the Paris Convention remain free to regulate the sale of certain types of goods - and the fact that a 
mark has been registered for such goods does not give the right to the holder of the registration to 
be exempted from any limitation of using the mark which may be decided by the competent 
authority of the country where the mark is registered”.62 
 
The Paris Convention, therefore, like the TRIPS Agreement, does not mandate a positive right to 
use a trademark. This conclusion is further reinforced by the following fact. An amendment to 
Article 7 of the Paris Convention was presented by the Association Internationale de la Propriété 
Intellectuelle (AIPPI) to the 1956 Lisbon Conference for the revision of this international treaty. It 
would have added to the said provision the following words: “The exclusive right of the owner or 
right holder to use a mark thus registered or renewed cannot be prohibited or limited when the sale 
to which it applies is legal”. Yet, the proposed amendment was not accepted. Such refusal does 
confirm that the Paris Convention has not incorporated any positive right to use a trademark.63 
 
Some commentators believe moreover that countries’ freedom to restrict or prohibit the use of 
trademarks would be significantly limited by another provision of the Paris Convention, i.e. Article 
6-quinquies(B),64 which is also incorporated by reference into TRIPS.65 This provision states that 
trademarks can be denied registration or the latter can be invalidated when they are contrary to 
morality or public order; when they are of such a nature as to deceive the public; when they are of 
such a nature as to infringe rights acquired by third parties in the country where protection is 
claimed; and when they are devoid of any distinctive character. Such provision, the arguments goes, 
- should be interpreted as meaning that not only registration but also the use of trademarks can be 
prevented exclusively on the above grounds. Countries would therefore be able to prohibit (not only 
the registration but also) the use of trademarks exclusively on the grounds mentioned in Article 6-
quinquies (B). 
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 Accepting this interpretation of the provision in question would prevent countries from adopting the 
packaging-related measures mentioned in the previous paragraphs as such measures do not fall 
within the grounds referred to in the article. Yet, this interpretation, again based on the (erroneous) 
assumption that the use of a trademark would be inextricably linked to its registration, cannot be 
accepted. 
 
Admittedly, it is undisputed that the grounds indicated in Article 6-quinquies(B) Paris Convention 
are not motivated by their registration being problematic, but rather by the fact that the use of the 
trademark would be.66 For example, registration of a sign which violates prior exclusive rights of a 
third party would be denied not because the registration itself is inherently wrong, but because of 
the damages to such third party and consumers’ confusion, which the use of the later sign 
provokes.67 Also, when a trademark office rejects an application, or when a court invalidates a 
registration, on deceptiveness grounds, the said office or court do so because they have assessed 
that the use of the trademark might mislead consumers as to certain characteristics of the goods on 
which the sign in question must be affixed. 
 
Such examples, however, do not support the interpretation in question. Indeed, in the circumstances 
mentioned above the reference to the use of trademark is simply instrumental, i.e. it is necessary to 
decide whether the registration should be granted or invalidated (it would be impossible to carry 
out such assessment without taking into consideration the use of the sign). In other words, the 
reference to the use of the signs on the market is merely ancillary as it allows trademark offices and 
judges to verify whether the trademark is registrable. The fact remains that registrability of 
trademarks, to be assessed in administrative or judicial proceedings also taking into account any 
possible use of the signs, should not be confused with their use.68 
 
We should therefore conclude that Article 6-quinquies(B) Paris Convention cannot be interpreted as 
extending its scope of application to trademark use, but it just covers registration related issues. It 
follows that all the measures mentioned in the previous paragraphs – which imply the prohibition or 
restriction on use of signs aimed at discouraging consumers from consuming tobacco, alcohol and 
unhealthy food – cannot be challenged under this provision. 
 
In any case, even interpreting Article 6-quinquies (B) Paris Convention in the opposite way and 
thus accepting that this provision also applies to uses of trademarks, such an interpretation would 
not significantly limit states’s freedom to prohibit uses of signs. This article should indeed be read 
in conjunction with Article 6(1) of the same treaty, which states that “the conditions for the filing 
and registration of trademarks shall be determined in each country of the Union by its domestic 
legislation”. In US - Section 211 Appropriation Acts the WTO Appellate Body gave a broad 
interpretation of this provision and reserved to countries wide legislative discretion when it comes 
to determining the conditions for accepting or refusing registrations, thus confirming that the Paris 
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Convention is quite liberal in terms of grounds upon which registration can be rejected.69 Thus, as 
has been noted, the reference to a right to use that stems from registration loses much of its strength 
since, if there is great scope for countries to reject registration, accordingly there would also be 
wide scope to prohibit the use of signs.70  
 
The “revocation” argument 
 
Some scholars have also stressed that, unlike other IP rights such as copyright (where the owner is 
not required to use the work in order to maintain protection), trademarks should be used to avoid 
revocation. In addition - they stress - in many jurisdictions applicants must show use or intention to 
use the sign in order to obtain the registration.71 This point would be in support of the view that 
trademark registrations also offer a positive right to use the sign. 
 
Such argument is also flawed. A look at Article 19 TRIPS is clarifying: “[…] the registration may 
be cancelled only after an uninterrupted period of at least three years of non-use, unless valid 
reasons based on the existence of obstacles to such use are shown by the trademark owner […]” 
(emphasis added). Similar provisions are contained in the EU Trademark Directive and Regulation, 
which rule out revocation if “there are proper reasons for non-use”.72 Also, the first part of Article 
19 TRIPS states: “If use is required to maintain a registration […]”. This wording means there may 
also be cases where use is not required to keep the registration alive.73 This is particularly true of 
the tobacco plain packaging legislation adopted by Australia which prohibits manufacturers to use 
non-word trademarks and limits the use of word signs. Such legislation prevents the refusal of a 
registration, or its revocation, merely because the owner is banned from using the sign on the 
products and their packaging.74 
 
Legitimate interests of trademark owners and promotion of harmful products 
 
Some commentators point to a specific finding of the WTO Panel in EC-Trademarks and 
Geographical Indications.75 They rely on such a finding to reiterate that the TRIPS Agreement 
provides owners of a registered trademark with legitimate interests which include the right to use 
the sign.76 The Panel, in particular, held that “every trademark owner has a legitimate interest in 
preserving the distinctiveness, or capacity to distinguish, of its trademark so that it can perform that 
function. This includes its interest in using its own trademark in connection with the relevant goods 
and services of its own and authorized undertakings. […]”.77 
 
I believe such statement does not lend weight to the “positive right” argument. First, the Panel 
referred to the concept of “legitimate interests” when interpreting Article 17 TRIPS, which does not 
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set rights for trademark owners but just deals with exceptions to such rights. It is therefore hard to 
claim that the finding in question has created a positive legal right to use a sign. Also, in the very 
same decision the Panel noted that the “legitimate interests” of trademark owners must be 
“something different” from full enjoyment of “legal rights”.78 This finding is further reinforced by 
the WTO Panel decision in Canada – Pharmaceutical Patents, a dispute related to the interpretation 
of Article 30 TRIPS, which sets forth the permitted exceptions to patent rights.79 The issue was 
whether the de facto extension of patent protection, which stemmed from potential competitors 
being unable to launch their products (generics) on the market the very same day the patent expires, 
was a “legitimate interest” of the patent owner. The Panel held it was not - and stressed that 
“legitimate interests” cannot be equated with “legal rights”. 80  
 
In any event, it should be noted that there are different kinds of interests in use of trademarks. As 
has been argued, use is not an end in itself in a trademark context.81 The interest in use of signs to 
minimise or prevent the likelihood of confusion between different brands is certainly legitimate, as 
it makes sure that consumers make educated purchase choices.82 Yet, there are also interests in use 
which a government may lawfully consider as not legitimate. For instance, while manufacturers of 
(legal, but) unhealthy products have still a legitimate interest in using trademarks for differentiating 
their goods from the ones sold by competitors, they nevertheless may not have legitimate interests 
in using their brand, e.g. in commercial ad messages and on the packaging, for promoting such 
products and deceiving consumers as to the effects on their health. 
 
Again the report of the WTO Panel in Canada - Pharmaceutical Patents reinforces this view. The 
Panel noted that “to make sense of the term ‘legitimate interests’ […], that term must be defined in 
the way that it is often used in legal discourse - as a normative claim calling for protection of 
interests that are ‘justifiable’ in the sense that they are supported by relevant public policies or other 
social norms. This is the sense of the word that often appears in statements such as ‘X has no 
legitimate interest in being able to do Y’”.83 It was eventually held that patents owners do not have 
any legitimate interests in the above mentioned de facto extension of patent protection, as such 
extension would unreasonably delay the entry into the market of generic drugs, which in turn would 
prevent consumers from buying cheaper medicines straight after the expiry of the relevant 
pharmaceutical patent.84 In other words, patentees’ interests in a de facto extension of protection is 
not legitimate as it is not supported by a relevant public policy. 
 
By the same token, trademark owners cannot claim a legitimate interest in the use of signs to 
promote harmful products and to deceive consumers as to the health risks associated with their 
consumption. Such an interest is not supported by a relevant public policy. On the contrary, a public 
policy is sound if it imposes for example (i) legislative bans on the promotion of harmful products, 
whatever shape that promotion takes, e.g. advertising in TV, radio, sport events or by using 
particularly eye-catching brands on the packaging; (ii) obligations to affix on the packaging large 
warnings about negative health consequences; (iii) bans on the use of sexy descriptors and colours 
on the packaging, which are capable of deceiving consumers about the real effects of the products 
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on their health. We have seen that such measures have been adopted or proposed in several 
countries in the field of tobacco, alcohol and (what is considered) unhealthy food, these measures 
aiming to correctly inform consumers and curb the promotional impact of the relevant brands.85 
 
A complaint by trademark holders would be reasonable should the regulatory measure in question 
also prevent manufacturers from totally distinguishing their products from those of competitors. Yet 
this is not the case with measures highlighted in the second part of the article as they still allow 
brands to be sufficiently recognisable by consumers. For instance, the ban on the use on the pack of 
descriptors such as “mild”, “light”, “ultra-light” and “low-tar”,86 in force in several jurisdictions,87 
does not prevent manufacturers from displaying their brands on the remaining part of the pack. This 
is exactly what the CJEU held in the proceedings involving the 2001 Tobacco Products Directive. 
Indeed the Court, called upon to examine the extent to which the prohibition of the above 
descriptors could infringe the fundamental right to property, including intellectual property and in 
particular trademark rights, noted that tobacco producers can keep using other distinctive signs on 
the packs. It indeed held that “[w]hile that article entails prohibition, in relation only to the 
packaging of tobacco products, on using a trade mark incorporating one of the descriptors referred 
to in that provision, the fact remains that a manufacturer of tobacco products may continue, 
notwithstanding the removal of that description from the packaging, to distinguish its product by 
using other distinctive signs”.88 
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This is also true of the most drastic measure highlighted in this work, namely the plain packaging of 
tobacco products adopted by Australia. Whilst this marketing restriction prevents tobacco 
manufacturers from displaying non-word elements of their trademarks (with a view to curbing any 
promotional effect), it nonetheless allows them to show their word trademarks on the pack, albeit in 
a standardised and neutral form.89 And word trademarks seem to be capable of distinguishing 
tobacco products in a retail environment.90 For example in Australia, even before legislation on 
plain packaging was passed in 2011, tobacco products could not (and still cannot) be displayed at 
the point of sale (so called “display ban”). The only indication of the cigaretters stock at the retail 
point is a list of the brands (word trademarks in a standard font and not accompanied by any fancy 
logo or image) and their price - 91 and tobacco consumers do make their purchase choice by relying 
on this list of word trademarks.92 The introduction of plain packaging in Australia, therefore, has 
not changed the way consumers choose their preferred cigarette pack. What this has done is to 
prohibit the use of fancy, colourful and eye-catching elements of tobacco brands outside the course 
of trade (i.e. on the packaging which is usually shown in public after sale),93 such ban aiming to 
prevent the promotion of what are unanimously considered harmful products. 
 
The main problem surrounding the mesaures highlighted in this article lies in the fact that it is not 
possible to curb the promotional effects of packaging without “touching” some distinctive elements 
of the brand: indeed the two elements of trademarks (promotional and distinctive) overlap. If 
goverments adopt measures aimed at neutralising the promotional effects of brands, it is inevitable 
that doing this will also lower their (abstract) distinctiveness.94 Yet, this is not unlawful under 
trademark law as long as consumers are still able to distinguish the products in question, as it seems 
here the case. 
 
Also, trademark owners could not challenge the packaging-related measures in question by 
invoking a loss in brand value. In particular, the Panel’s statement in EC-Trademarks and 
Geographical Indications that “taking account of that legitimate interest will also take account of 
the trademark owner’s interest in the economic value of its mark”95 cannot be relied on to oppose 
the measures at issue.96 It could not be invoked, in particular, to imply a positive right to use 
trademarks. Indeed, in the past, public authorities have adopted measures in the public interest that 
had the effect of reducing the value of brands (e.g., ban on advertising of tobacco products in TV, 
radio, sport events and ban on products placement), without owners formally complaining about a 
violation of an alleged right to use the brand. 
 
Harmfulness of the product and IP analysis 
                                                 
89
 Alberto Alemanno and Enrico Bonadio, “Do You Mind My Smoking? Plain Packaging of Cigarettes Under the 
TRIPS Agreement” (2011) The John Marshall Review of Intellectual Property Law, 10(3), p. 457, fn. 45. 
90
 In my previous co-authored work, cited above fn. 89, pp. 456-457, I also reported opposite opinions from several 
sources, including tobacco companies, highlighting a possible clash between plain packaging and tobacco trademarks’ 
distinctiveness. 
91
 Davison and Emerton, cited above fn. 39,  p. 510-511. 
92
 Regular smokers often do not even look at the list of brands before purchasing the pack. They already know which 
brand they want to buy. See also Marsoof, cited above fn. 44, p. 209 (noting that “it is hard to immagine that a hard-
core smoker would get confused as to the product he desires”). 
93
 The primary impact of plain packaging is in social settings after customers have purchased the tobacco product: see 
Mark Davison, “International Intellectual Property Law”, in Tania Voon, Andrew Mitchell and Jonathan Liberman 
(eds), Regulating Tobacco, Alcohol and Unhealthy Foods – The Legal Issue (Routledge, 2014), p. 142. 
94
 Davison, cited above fn. 174, p. 170. 
95
 European Communities — Protection of Trademarks and Geographical Indications for Agricultural Products and 
Foodstuffs (Complaint by United States), WT/DS174/R, report of 15 March 2005, paragraph 7.664. 
96
 The Panel’s statement in question has been invoked by some opponents of plain packaging of cigarettes: see for 
example Lalive, cited above 54, pp. 9-10 (and also cited in my and Alberto Alemanno’s work, cited above fn. 89, p. 
461). 
 One might also argue that the fact that a product is harmful to consumers’ health should not be 
invoked as a justification to prohibit or restrict the use of the relevant brands. It has been noted that 
“while many disagree with the use and sale of tobacco, this is not the issue here, nor should the 
nature of the product dictate the outcome of an intellectual property analysis”.97 
 
I believe this argument is flawed. The nature of the product is relevant and in certain circumstances 
may influence the outcome of IP analyses, especially when it comes to trademarks, designs and 
patents.98 For instance, as we have seen,99 when a trademark office rejects an application, or when a 
court invalidates a registration, on deceptiveness grounds, the said office or court does so because it 
has taken into consideration the nature of the goods upon which the sign in question must be placed. 
In several circumstances, therefore, trademarks and the products upon which they are affixed cannot 
be considered as separate entities. 
 
Thus, my point is that the harmfulness of products is relevant – and public authorities reserve the 
right to adopt measures aimed at discouraging the consumption of such products by curbing the 
deceptive and promotional elements of their brands. And trademark owners cannot challenge these 
measures, especially the ones highlighted in this work, by invoking (non-existent) positive rights to 
use trademarks. 
 
Take also the example of cannabis. If countries want to legalise the consumption of cannabis (and 
there are several governments which have already done so, or are currently discussing this 
legislative option), they may also want to protect consumers’ health and thus prevent marijuana and 
hashish manufacturers and distributors to use colourful and eye-catching brands to promote their 
consumption.100 Should we allow cannabis growers and distributors to stop these countries to 
pursue this legitimate public interest by permitting them to claim a positive right to use trademarks? 
My answer is no. 
 
The privilege to use a sign 
 
We have seen that trademark registrations do not confer on their owners a positive right to use the 
sign. Mark Davison and Patrick Emerton interestingly argue, by building upon the concepts 
developed by Wesley Hohfeld,101 that trademark owners only enjoy a privilege of using their 
trademarks, which is different from a right to use it.102 A privilege – Davison and Emerton explain - 
is not a right in its strict sense. It is just a legal permission to engage in conduct. In the absence of 
trademark legislations - the argument goes - any person would have the privilege of using a sign. 
That is why registrations are granted, namely in order to offer exclusive rights to prevent third 
parties from exploiting the brand as well as to restrict the privilege to use a trademark. Yet, 
privileges may be defeasible: in other words they may be taken away by public authorities when it 
comes to pursuing public interests.103 
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 The regulatory measures highlighted above104 are good examples of cases where public authorities 
lawfully defeat tobacco, alcohol and (unhealthy) food manufacturers’ privileges to fully use their 
signs on packaging. In these circumstances governments’ interest in preventing or restricting the 
use of brands which promote the consumption of harmful products and convey deceptive messages 
about their health consequences, i.e. legitimate public interests, outweighs the privilege to fully use 
those signs.105 
 
Article 20 TRIPS 
 
Article 20 TRIPS Agreement is an important provision for the present analysis as it deals with use 
of trademarks. It states that “the use of a trademark in the course of trade shall not be unjustifiably 
encumbered by special requirements, such as use with another trademark, use in a special form or 
use in a manner detrimental to its capability to distinguish the goods or services of one undertaking 
from those of other undertakings”. 
 
A scholar noted that this provision would imply a positive right to use a trademark “because 
otherwise there would be no need to cabin the power of WTO Members to ‘encumber’ such use”.106 
It would follow that Article 20 would represent a big obstacle for governments that wish to prohibit 
or restrict the use of brands. 
 
First (and again), this argument seems flawed for the reasons highlighted above at the paragraph 
“The alleged ‘spirit’ of international trademark law”. The view that Article 20 does not create a 
right to use107 is further reinforced by the legislative practice of many countries in the specific field 
of tobacco. In the latest years several states have indeed imposed tobacco advertising restrictions 
which entail the inability of manufacturers to fully use tobacco brands. As has been rightly 
argued,108 such a practice constitutes “subsequent practice in the application of the treaty which 
establishes the agreement of the parties regarding its interpretation” (Article 31(3)(b) of the Vienna 
Convention on the Laws of Treaties)109 and is therefore relevant to an interpretation of Article 20 
TRIPS. This practice should therefore lend weight to an interpretation of this provision which does 
not imply any positive right to use a trademark. After all, none has ever formally complained by 
arguing that tobacco advertising restrictions curtail an implied right to use brands. 
 
It is important to stress that Article 20 does not ban a complete prohibition on the use of trademarks, 
but just (unjustifiable) positive encumbrances, namely the possibility for governments to mandate 
specific requirements about how to use brands.110 The three examples referred to in Article 20 (i.e., 
use with another trademark, use in a special form or use in a manner detrimental to its capability to 
distinguish the goods or services of one undertaking from those of other undertakings)111 confirms 
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this interpretation as they all refer to actual use of brands.112 A typical example of unjustifiable 
positive encumbrance, which Article 20 prohibits, is an obligation on foreign owners to use their 
brands together with the signs of local licensees.113 According to this interpretation of the TRIPS 
provision, therefore, total bans on the use of trademarks or some of their elements are lawful, as 
such measures do not provide any positive encumbrance on the use of brands (e.g., the prohibition 
to use non-word signs triggered by the plain packaging in Australia; the ban on the use of 
descriptors and colours on cigarettes packs; and the South African and EU bans on the use of baby-
related logos on infant formula packaging). Basically, they are not regulated (and therefore 
proibited) by Article 20.114 
 
What about positive encumbrances on the use of trademarks triggered by the imposition of large 
health warnings on tobacco, alcohol and food packaging? These measures are indeed encumbrances 
on the use of trademarks as the space for affixing brands is reduced. The same holds true for the 
plain packaging of cigarettes adopted by Australia which dictates a much reduced, standard and 
neutral font for word trademarks. Are such encumbrances “justifiable” and therefore allowed by 
Article 20 TRIPS? I believe so. They are justifiable as they aim to promote public health.115 In other 
words, “justifiability” here refers to the legitimate interests of governments to protect a public 
interest by encumbering the promotional and deceptive use of brands in connection with unhealthy 
products.116 
 
What Article 20 entails is basically a balancing exercise between various interests and rights, 
including interests of trademark owners in using their signs for distinctive purposes and the right of 
governments in preventing uses of brands which mislead consumers about health consequences and 
promote harmful products.117 And it seems that the measures in question guarantee a justifiable 
balance between curtailing the promotion of tobacco, alcohol and unhealthy foodstuff (a 
governments’ right) and allowing the differentiation of the goods in question.118 For example, we 
have seen that after the adoption of the regulatory measures at issue trademark owners can still 
distinguish their products by using word signs on packs, although in a strandardised format (in case 
of plain packaging adopted by Australia) or even their original brands, although in a reduced space 
of the packaging (in case of mandatory health warnings on tobacco, alcohol and foodstuff 
packaging).119 
 
Effectiveness of the measures in question 
 
                                                                                                                                                                  
‘that are detrimental to [their] capability to distinguish the goods or services of one undertaking from those of other 
undertakings’”). 
112
 Davison, cited above fn. 62, p. 162. 
113
 Before TRIPS some developing countries, including Brazil, Mexico and India, sought to strenghten the contractual 
power of local licensees towards foreign partners, and requested that the licensed trademark be used together with the 
sign used by the former. Such measures now would not be permitted under Article 20 TRIPS. 
114
 Carvalho, cited above fn. 107, p. 441, fn. 975 (noting that the use of brands may be suppressed by governments). 
115
 See also Carvalho, cited above fn. 107, pp. 441-442 (arguing that the imposition of health warnings and notices on 
the risk of consumption of harmful products, size and colours of letters and characters of brands are to be considered 
justifiable under Article 20 TRIPS). 
116
 Davison and Emerton, cited above fn. 39, p. 566. 
117
 Davison and Emerton, cited above fn. 39, p. 567. 
118
 Davison, cited above fn. 93, p. 142.   
119
 As far as tobacco-related measures are concerned, see again the CJEU’s decision on the ban on the use on the pack 
of descriptors such as “mild”, “light”, “ultra-light” and “low-tar” in the proceedings involving the 2001 Tobacco 
Products Directive. As we have seen, in that ruling the Court basically held that the prohibition in question is 
proportionate to the aim pursued (i.e. reducing tobacco consumption) as manufacturers can keep using other distinctive 
signs on the packs: see Case C-491/01, The Queen v. Secretary of State for Health, ex parte British American Tobacco 
(Investments) Ltd and Imperial Tobacco Ltd, decision of 10 December 2002, paragraph 152. 
The measures analysed in this article seem also effective. Australia, for example, has justified its 
legislation on plain packaging of tobacco products by relying on – what I believe is - convincing 
evidence.120 Recent figures released by the Australian Bureau of Statistics (ABS) also show that 
total consumption of tobacco and cigarettes in the first quarter of 2014 in Australia is the lowest 
ever recorded.121 Moreover, the introduction of plain pakaging has triggered a significant spike in 
Australian callers to Quitlinet, the telephone helpline offering treatment for addiction and behaviour 
change.122 
 
The above data indirectly show that the “brand switching” theory, invoked by the tobacco industry 
to dispute the effectiveness of plain packaging, is not really convincing. According to this theory, 
the use of tobacco brands on packaging would just be capable of making consumers shift from one 
brand to another (say, from Marlboro to Camel) and would not therefore be “an invitation to 
consume”123 for non smokers. On the contrary trademarks, especially when affixed on packaging of 
products like tobacco (whose main competitive asset is exactly the packaging), are not just about 
distinguishing brands and acquiring market share of competitors. They are also about expanding the 
size of the market by convincing new consumers to use the relevant product.124 
 
Convincing evidence has also been brought in relation to health warnings. For example, as far as 
tobacco and alcoholic products are concerned, early and recent research has shown that such 
warnings are effective in raising awareness of health risks stemming from tobacco and alcohol 
consumption and influencing health related behaviours.125 
 
There appears therefore to be a causal link between the measures in question and the protection of 
the specific public interest, i.e. consumers’ health, in the sense that such measures are capable of 
meeting the desired target. The governments that have introduced them seem thus able to justify the 
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measures under Article 8 TRIPS, which entails a suitability test: “Members may, in formulating or 
amending their laws and regulations, adopt measures necessary to protect public health and 
nutrition, and to promote the public interest in sectors of vital importance to their socio-economic 
and technological development […]”.126 This provision has not been interpreted thus far by a WTO 
adjudicatory body.127 Yet, the provision of another WTO agreement, i.e. Article XX GATT (which 
allows states to restrict the trade of goods if it is necessary to protect human health), and the way it 
has been interpreted by the WTO Panels and the Appellate Body on several occasions, could be 
here relevant.128 For instance, in Brazil – Retreated Tyres the Appellate Body found that a country 
trying to justify its measure under Article XX GATT should show that such measure “brings about 
a material contribution to the achievement of its objectives”.129 This finding could be applied, 
mutatis mutandis, to Article 8 TRIPS and the measures highlighted in the article: indeed, there is 
little doubt that the evidence gathered in support of them show that these measures at least bring 
about a “material contribution” to consumers’ health. 
 
Conclusion 
 
This article has made the point that economic operators do not have complete freedom to use 
trademarks, and public authorities have the right and duty to restrict such freedom if that is 
necessary to protect consumers’ health. 
 
Brands can therefore be subject to regulatory interventions, which impair their ability to be 
exploited in the course of trade. The packaging-related measures analysed in the article are good 
examples of such intervention. They aim, in particular, at correctly informing consumers about the 
health risks stemming from the consumption of tobacco, alcohol and unhealthy foodstuff and 
convincing them not to consume such products. As has been argued with particular reference to 
tobacco, these measures neutralise and replace the market-driven positive associations conveyed by 
the brand.130 
 
What is important to stress is that such measures do not actually prevent consumers from 
purchasing and use the product which is deemed harmful. The products in question remain legal, 
and everybody has the freedom to buy and consume them. What governments aim to achieve by 
prohibiting or restricting the use of brands in connection with these goods is just to push members 
of the public to behave the way they deem is correct, i.e. not to consume said products. The idea is: 
“we don’t mandate people, we just suggest them what is best for them”. 
 
More importantly, the measures in question do not violate trademark-related provisions of the 
TRIPS Agreement and the Paris Convention because trademark registrations do not offer a positive 
right to use the sign, which can then be prohibited or restricted by public authorities to further 
public interests. The opposing argument focused on an alleged purposive interpretation of 
international trademark provisions (which suggests that a trademark registration would be closely 
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linked to use, and that the former would generate the right to the latter) should be refused. After all, 
that registrations offer just negative rights to use the brand has already been confirmed by the WTO 
Panel in EC – Trademarks and Geographical Indications –131 and it is likely that the WTO Panel’s 
decision in the disputes brought against Australian legislation on plain packaging will soon reiterate 
such (in my opinion, right) interpretation. 
 
Finally, the measures in question seem to be effective in light of the evidence thus far gathered. In 
other words, the prohibitions and restrictions on the use of brands analysed in the article are capable 
of meeting the desired target, i.e. consumers’ health. They also seem proportionate to such aim as 
tobacco, alcohol and food manufacturers are still able to use their brands, although in a neutral and 
strandardised format or in a reduced space of the packaging, thus guaranteeing a balance between 
the need to curb the promotional aspects of these trademarks and the need to differentiate the 
relevant products on the market. 
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